Literature DB >> 8404679

Up-regulation of beta 1-adrenoceptor messenger ribonucleic acid in the rat pineal gland: nocturnally, through a beta-adrenoceptor-linked mechanism, and in vitro, through a novel posttranscriptional mechanism activated by specific protein synthesis inhibitors.

D A Carter1.   

Abstract

The uniquely high concentration of beta 1-adrenoceptor mRNA (beta 1-mRNA) in the pineal gland provides a model for the regulation of GTP-binding protein (G-protein)-linked receptor gene expression within a functioning endocrine gland. By Northern analysis it has been shown that a nocturnal up-regulation of beta 1-mRNA in the rat pineal results in a 2.6-fold increase in mRNA levels at the middark phase (2400 h) compared with those at the midlight phase (1200 h). This increase is blocked by administration of the beta-adrenoceptor antagonist propranolol before the onset of darkness. In vitro studies of beta 1-mRNA expression in organ-cultured pineals has confirmed beta-adrenoceptor-linked up-regulation of beta 1-mRNA. Treatment of cultured pineals with the second messenger drugs forskolin and phorbol 12,13-dibutyrate produced mRNA responses that were again consistent with a primary role of beta-adrenoceptors in the up-regulation of beta 1-mRNA. Nuclear run-on analysis showed that the acute up-regulation of mRNA was mediated largely through a transcriptional mechanism. An additional novel mode of regulation of beta 1-mRNA was also identified; the protein synthesis inhibitors anisomycin and cycloheximide, but not puromycin and emetine, elicited an acute increase in beta 1-mRNA in cultured pineals that was not transcriptionally mediated. The mechanism underlying this mode of regulation is discussed with relation to control of the cellular immediate early gene c-fos. The facility to examine both physiological and in vitro changes in beta 1-mRNA expression in the pineal will provide further insight into the complexity that is apparent for the molecular regulation of G-protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404679     DOI: 10.1210/endo.133.5.8404679

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Developmental and diurnal dynamics of Pax4 expression in the mammalian pineal gland: nocturnal down-regulation is mediated by adrenergic-cyclic adenosine 3',5'-monophosphate signaling.

Authors:  Martin F Rath; Michael J Bailey; Jong-So Kim; Anthony K Ho; Pascaline Gaildrat; Steven L Coon; Morten Møller; David C Klein
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

2.  p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide.

Authors:  Do Kyung Kim; Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

3.  Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes.

Authors:  T Bengtsson; B Cannon; J Nedergaard
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

4.  Diurnal variation of the adenylyl cyclase type 1 in the rat pineal gland.

Authors:  E T Tzavara; Y Pouille; N Defer; J Hanoune
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways.

Authors:  K Furukawa; S Estus; W Fu; R J Mark; M P Mattson
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.